- Home
- ABAT vs NMRA Comparison
ABAT vs NMRA Comparison
Compare ABAT & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABAT | NMRA |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | |
| Sector | Basic Materials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 517.0M | 554.0M |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ABAT | NMRA |
|---|---|---|
| Price | $3.09 | $1.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | $6.00 | ★ $7.50 |
| AVG Volume (30 Days) | ★ 5.9M | 1.2M |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.14 | 5.23 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $145.40 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $0.72 |
| 52 Week High | $11.49 | $3.65 |
Technical Indicators
Market Signals| Indicator | ABAT | NMRA |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 34.34 |
| Support Level | $2.35 | $1.46 |
| Resistance Level | $3.67 | $1.99 |
| Average True Range (ATR) | 0.30 | 0.12 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 24.59 | 4.05 |
Price Performance
Historical ComparisonAbout ABAT American Battery Technology Company
American Battery Technology Co is an integrated critical battery minerals company that develops technologies for both primary battery minerals manufacturing and lithium-ion battery recycling. It operates battery recycling facilities that process materials from electric vehicle batteries, stationary battery energy storage systems, and consumer electronics. Additionally, the company advances lithium production projects using proprietary technology to produce battery-grade lithium hydroxide. It generates revenue mainly from its recycling operations and is expanding capacity with strategic partnerships and government grants. The company's activities focus on creating a closed-loop battery materials supply chain to support sustainable manufacturing in the United States.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.